M. Hussey

发表

Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice.

N. Morrell, K. Sheppard, L. Ciuclan, 2013, The American journal of pathology.

Targeting the serotonin pathway for the treatment of pulmonary arterial hypertension.

N. Press, L. Ciuclan, M. Hussey, 2013, Pharmacology & therapeutics.

Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity.

C. Ledent, Jian-Mei Li, I. Kitchen, 2008, Free radical biology & medicine.

Sex-dependent influence of endogenous estrogen in pulmonary hypertension.

D. Rowlands, M. Maclean, M. Nilsen, 2014, American journal of respiratory and critical care medicine.

Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related Hydroxylases

Matthew Thomas, David Rowlands, Clemens Scheufler, 2017, Front. Pharmacol..

A novel murine model of severe pulmonary arterial hypertension.

J. Westwick, N. Morrell, A. Holmes, 2011, American journal of respiratory and critical care medicine.

Deletion of the adenosine A2A receptor in mice enhances spinal cord neurochemical responses to an inflammatory nociceptive stimulus

C. Ledent, S. Hourani, I. Kitchen, 2012, Neuroscience Letters.

Genetic deletion of the adenosine A2A receptor in mice reduces the changes in spinal cord NMDA receptor binding and glucose uptake caused by a nociceptive stimulus

C. Ledent, S. Hourani, I. Kitchen, 2010, Neuroscience Letters.

Reduced response to the formalin test and lowered spinal NMDA glutamate receptor binding in adenosine A2A receptor knockout mice

Geoffrey D. Clarke, Ian Kitchen, C. Ledent, 2007, PAIN.

Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension.

P. Furet, I. Konstantinova, A. Saunders, 2016, Journal of medicinal chemistry.

Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.

I. Clay, J. Westwick, D. Rowlands, 2013, American journal of respiratory and critical care medicine.